SPXC Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
SPX Technologies Inc (SPXC) is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The company has strong financial growth, positive analyst sentiment, and a promising outlook for 2026, supported by acquisitions and capacity expansion. Despite some insider selling, hedge fund interest and favorable options data indicate positive sentiment.
The technical indicators show mixed signals. The MACD histogram is negative and expanding, suggesting bearish momentum. However, the moving averages are bullish (SMA_5 > SMA_20 > SMA_200), and the RSI is neutral at 45.772. The stock is trading near a key support level (S1: 221.755) with resistance at 245.103, indicating potential upward movement.
Hedge funds are significantly increasing their holdings, with a 476.98% rise in buying activity last quarter.
Analysts have raised price targets significantly, with multiple firms projecting $270+ and highlighting strong growth potential in HVAC and D&M segments.
The company reported robust Q4 2025 earnings, with adjusted EPS growth of 21% YoY and a positive outlook for
Strategic acquisitions, including Crawford United, are expected to drive further growth.
Insiders are selling, with a 664.99% increase in selling activity over the last month.
MACD indicates bearish momentum, which could signal short-term weakness.
SPX Technologies reported strong financial performance in Q3 2025, with revenue increasing by 22.56% YoY to $592.8M, net income up 24.90% YoY to $62.7M, and EPS rising 20.75% YoY to $1.28. However, gross margin declined slightly to 36.25%, down -3.13% YoY. For Q4 2025, adjusted EPS was $1.88, in line with estimates, and full-year adjusted EPS grew 21% to $6.76.
Analysts are highly optimistic about SPXC, with multiple firms raising price targets significantly (e.g., Oppenheimer to $272, B. Riley to $270, Wells Fargo to $270, BofA to $280). The consensus highlights strong growth in HVAC and D&M segments, supported by acquisitions, capacity expansion, and a robust backlog. Ratings range from Buy to Outperform, with no major downgrades.
